Holder evidence
10
SEC ownership of Ampio Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001411906.
Lead holder
Michael Macaluso
13D/G signal
—
Latest evidence
09 Jun 2023
- CIK
- 0001411906
- Location
- Englewood, CO
- SEC evidence mix
- 3/4/5
- Lead holder
- Michael Macaluso
- Latest evidence date
- 09 Jun 2023
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Ampio Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Michael Macaluso
13D/G signal
—
Evidence rows
10
Latest as of
09 Jun 2023
3/4/5
Highest disclosed value: $754,654
Showing 1-8 of 10 holder rows.
Rank 1 holder
Michael Macaluso
3/4/5
- Ownership
- —
- Position
- $754.7K
Rank 2 holder
Holli Cherevka
3/4/5
- Ownership
- —
- Position
- $118.1K
Rank 3 holder
Dan Stokely
3/4/5
- Ownership
- —
- Position
- $89.8K
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Michael Macaluso |
3/4/5
Director
|
—
class O/S missing
|
$754,654
2,624,882 shares
|
— | 01 Jan 2022 |
| Holli Cherevka |
3/4/5
PRESIDENT AND COO
|
—
class O/S missing
|
$118,111
410,820 shares
|
— | 01 Jan 2022 |
| Dan Stokely |
3/4/5
CFO
|
—
class O/S missing
|
$89,779
312,274 shares
|
— | 01 Jan 2022 |
| J. Kevin Buchi |
3/4/5
Director
|
—
class O/S missing
|
$42,222
146,858 shares
|
— | 09 Jun 2023 |
| David R. Stevens |
3/4/5
Director
|
—
class O/S missing
|
$29,892
103,971 shares
|
— | 11 May 2023 |
| Michael A. Martino |
3/4/5
CEO, Director
|
—
class O/S missing
|
$22,106
76,890 shares
|
— | 24 May 2023 |
| Elizabeth Varki Jobes |
3/4/5
Director
|
—
class O/S missing
|
—
150,000 shares
|
— | 01 Mar 2022 |
| David Bar-Or |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 09 Feb 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 31 May 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to Ampio Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Lead holder
Michael Macaluso
Net 12M change
$0
Latest report
09 Jun 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael Macaluso | Director | $754,654 | Mixed | 01 Jan 2022 | ||
| Holli Cherevka | President And Coo | $118,111 | Mixed | 01 Jan 2022 | ||
| Dan Stokely | Cfo | $89,779 | Mixed | 01 Jan 2022 | ||
| J. Kevin Buchi | Director | $42,222 | Filing P/S | 09 Jun 2023 | ||
| David R. Stevens | Director | $29,892 | Mixed | 11 May 2023 | ||
| Michael A. Martino | CEO, Director | $22,106 | Mixed | 24 May 2023 | ||
| Elizabeth Varki Jobes | Director | Mixed | 01 Mar 2022 | |||
| David Bar-Or | Director | Mixed | 09 Feb 2022 | |||
| Richard B. Giles | Director | Mixed | 30 Dec 2021 | |||
| Philip H. Coelho | Director | Mixed | 30 Dec 2021 |
Recent insider transactions for Ampio Pharmaceuticals, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* indicates a reported price that failed the local validity check.